Article: Fixing Imbalanced NAD Metabolism Reduces Effects of Telomere Dysfunction: Preclinical Findings

PrevNext
Neurological Health Parkinson's Disease Preclinical

Fixing Imbalanced NAD Metabolism Reduces Effects of Telomere Dysfunction: Preclinical Findings

Synopsis

Short telomeres cause diseases like dyskeratosis congenita (DC), which lack effective treatments. This study found that cells from DC patients and telomerase-deficient mice have low NAD+ levels and an imbalance in enzymes controlling NAD+ metabolism. These changes led to problems with telomere damage, mitochondrial function, and cell aging. Supplementing with nicotinamide riboside (NR) or inhibiting an enzyme that breaks down NAD+ (CD38) restored NAD+ balance and improved cellular defects. This shows that NAD+ dysregulation is a key factor in telomere diseases and that targeting NAD+ metabolism could offer new treatments.

Journal

The EMBO Journal

Share

Read more

Preclinical

Nicotinamide Riboside Protects Optic Nerve from Degeneration: Preclinical Findings

Synopsis Nicotinamide riboside (NR), a precursor to NAD+, protects optic nerve axons from damage caused by tumor necrosis factor (TNF). In rats, NR reduced axon loss, improved autophagy markers (i...

Read more
Neurological Health

Nicotinamide Riboside Reduces Chemotherapy-Induced Peripheral Neuropathy and Suppresses Tumor Growth: Preclinical Findings

Synopsis Nicotinamide riboside (NR) is a vitamin B3 precursor of NAD+ that blunts diabetic and chemotherapy-induced peripheral neuropathy in preclinical models. This study tested whether NR also r...

Read more